AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11916767 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium citrate malate and vitamin D supplementation
Number of subjects: 342
Study 11916767 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 342
Study 9641437 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue group (experimental group)
Number of subjects: 20
Study 9641437 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 7854793 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan 13.5 mg t.d.s.
Number of subjects: 19
Study 7854793 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan 27 mg t.d.s.
Number of subjects: 19
Study 7854793 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 7854793 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan
Number of subjects: 19
Study 2769578 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education program (four one-hour classes over two weeks)
Number of subjects: 24
Study 2769578 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 24
Study 877449 — intervention group
Group type: COMPARATOR
Intervention: Air at 28°C
Number of subjects: 6
Study 877449 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiphoid immersion
Number of subjects: 6
Study 877449 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest immersion
Number of subjects: 6
Study 877449 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower limb submergence
Number of subjects: 6
Study 877449 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdomen immersion
Number of subjects: 6
Study 877449 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip level immersion
Number of subjects: 6
Study 877449 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdomen submergence
Number of subjects: 6
Study 877449 — intervention group
Group type: EXPERIMENTAL
Intervention: Throughout the study
Number of subjects: 6
Study 31507087 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekend adherence
Number of subjects: 136
Study 31507087 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention adherence
Number of subjects: 136
Study 31507087 — intervention group
Group type: COMPARATOR
Intervention: Control group adherence
Number of subjects: 136
Study 31592976 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional acupuncture (TA)
Number of subjects: 19
Study 31592976 — intervention group
Group type: COMPARATOR
Intervention: Non-traditional acupuncture (NTA)
Number of subjects: 19
Study 28029510 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-Solving Therapy (PST)
Number of subjects: 122
Study 28029510 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 122
Study 28029510 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study 26612290 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamstring (HS) tendon autograft
Number of subjects: 106
Study 26612290 — intervention group
Group type: COMPARATOR
Intervention: Bone-patellar tendon-bone allograft
Number of subjects: 106
Study 24034947 — intervention group
Group type: EXPERIMENTAL
Intervention: American cluster (more acculturated)
Number of subjects: 0
Study 24034947 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicultural cluster (more acculturated)
Number of subjects: 0
Study 24034947 — intervention group
Group type: EXPERIMENTAL
Intervention: SL‐ASIA summary score (one point increase)
Number of subjects: 0
Study 24034947 — intervention group
Group type: COMPARATOR
Intervention: Asian cluster (less acculturated)
Number of subjects: 0
Study 21562412 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone phosphate (DP) 15 mg
Number of subjects: 60
Study 21562412 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone acetate (MPA) 80 mg
Number of subjects: 60
Study 18311844 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 40
Study 18311844 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 40
Study 17053536 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 15245
Study 17053536 — intervention group
Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 15245
Study 14521705 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.005% calcipotriol ointment applied twice a day
Number of subjects: 36
Study 14521705 — intervention group
Group type: COMPARATOR
Intervention: 5% coal tar ointment applied overnight once daily
Number of subjects: 36
Study 14521705 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.005% calcipotriol ointment
Number of subjects: 36
Study 14521705 — intervention group
Group type: COMPARATOR
Intervention: 5% coal tar ointment
Number of subjects: 36
Study 10930152 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (ddI) + Stavudine (d4T)
Number of subjects: 78
Study 10930152 — intervention group
Group type: COMPARATOR
Intervention: Didanosine (ddI) alone
Number of subjects: 78
Study 10930152 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose ddI
Number of subjects: 78
Study 9058316 — intervention group
Group type: EXPERIMENTAL
Intervention: low‐dose natural interferon‐alpha (nIFN alpha) for 6 months
Number of subjects: 237
Study 9058316 — intervention group
Group type: COMPARATOR
Intervention: 6 cycles of maintenance chemotherapy (CAP)
Number of subjects: 237
Study 9058316 — intervention group
Group type: COMPARATOR
Intervention: no maintenance therapy (control group)
Number of subjects: 237
Study 8437528 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous molsidomine (4 mg) on the first day
Number of subjects: 10
Study 8437528 — intervention group
Group type: COMPARATOR
Intervention: Oral molsidomine (4 mg) on the first day
Number of subjects: 10
Study 8437528 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral molsidomine (4 mg) on the second day
Number of subjects: 10
Study 8437528 — intervention group
Group type: COMPARATOR
Intervention: Intravenous molsidomine (4 mg) on the second day
Number of subjects: 10
Study 30871518 — intervention group
Group type: EXPERIMENTAL
Intervention: NLP algorithm for identifying social isolation
Number of subjects: 4195
Study 29509068 — intervention group
Group type: EXPERIMENTAL
Intervention: CS images
Number of subjects: 160
Study 29509068 — intervention group
Group type: EXPERIMENTAL
Intervention: CS written message
Number of subjects: 160
Study 27379388 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (1.5 mg/kg bolus followed by 2 mg/kg/h infusion)
Number of subjects: 58
Study 27379388 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 58
Study 24678983 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of Chronic Illness Care (ACIC) survey
Number of subjects: 283
Study 24678983 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management Support (ACIC subscale)
Number of subjects: 283
Study 24678983 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Linkages (ACIC subscale)
Number of subjects: 283
Study 24678983 — intervention group
Group type: EXPERIMENTAL
Intervention: Delivery System Design (ACIC subscale)
Number of subjects: 283
Study 24678983 — intervention group
Group type: EXPERIMENTAL
Intervention: Organizational Support (ACIC subscale)
Number of subjects: 283
Study 22563851 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated educational messages and consecutive two-month free trials with each of four POU products (n = 600)
Number of subjects: 800
Study 22563851 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 200)
Number of subjects: 800
Study 20484968 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical antioxidant pretreatment for 2 weeks
Number of subjects: 0
Study 20484968 — intervention group
Group type: COMPARATOR
Intervention: UVA irradiation
Number of subjects: 0
Study 18786346 — intervention group
Group type: EXPERIMENTAL
Intervention: Quad helix appliance
Number of subjects: 41
Study 18786346 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid palatal expansion with an acrylic bonded appliance
Number of subjects: 41
Study 18786346 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid palatal expansion after uprighting the upper molars with a Quad helix appliance
Number of subjects: 41
Study 15818099 — intervention group
Group type: EXPERIMENTAL
Intervention: Thin computed tomography sections
Number of subjects: 30
Study 15818099 — intervention group
Group type: COMPARATOR
Intervention: Thick computed tomography sections
Number of subjects: 30
Study 12446164 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with pregnancy-related pain in the pelvis
Number of subjects: 9
Study 12446164 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 9
Study 10599726 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticotropin-releasing hormone (CRH) infusion (1 microg/kg x h in saline)
Number of subjects: 12
Study 10599726 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 12
Study 10599726 — intervention group
Group type: EXPERIMENTAL
Intervention: CRH infusion
Number of subjects: 12
Study 8951940 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous morphine administration
Number of subjects: 10
Study 8951940 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine administration
Number of subjects: 10
Study 1929450 — intervention group
Group type: EXPERIMENTAL
Intervention: UFT 400 mg/day
Number of subjects: 0
Study 1929450 — intervention group
Group type: COMPARATOR
Intervention: FT 600 mg/day
Number of subjects: 0
Study 6358542 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 3837
Study 6358542 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3837
Study 30380116 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric citrate
Number of subjects: 232
Study 30380116 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 232
Study 29040031 — intervention group
Group type: EXPERIMENTAL
Intervention: ATLG (20 mg/kg per day on days -3, -2, -1)
Number of subjects: 254
Study 29040031 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study 27121596 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovaza (3.36 g daily for 1 year)
Number of subjects: 6
Study 27121596 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Lovaza)
Number of subjects: 6
Study 24172159 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotropic medication use (lifetime and 12-month)
Number of subjects: 2000
Study 24172159 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiolytics
Number of subjects: 2000
Study 24172159 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 2000
Study 24172159 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative medicines
Number of subjects: 2000
Study 24172159 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotics
Number of subjects: 2000
Study 24172159 — intervention group
Group type: EXPERIMENTAL
Intervention: Mood stabilizers
Number of subjects: 2000
Study 24172159 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotics
Number of subjects: 2000
Study 24172159 — intervention group
Group type: COMPARATOR
Intervention: Psychiatric case identification
Number of subjects: 2000
Study 24172159 — intervention group
Group type: COMPARATOR
Intervention: Female gender
Number of subjects: 2000
Study 24172159 — intervention group
Group type: COMPARATOR
Intervention: Age
Number of subjects: 2000
Study 24172159 — intervention group
Group type: COMPARATOR
Intervention: Marital status (being married)
Number of subjects: 2000
Study 24172159 — intervention group
Group type: COMPARATOR
Intervention: Income
Number of subjects: 2000
Study 21209073 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramyocardial bone marrow cell injection
Number of subjects: 50
Study 21209073 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 19137353 — intervention group
Group type: COMPARATOR
Intervention: 20 mg triamcinolone acetonide (steroid group)
Number of subjects: 40
Study 19137353 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg sodium hyaluronate (hyaluronate group)
Number of subjects: 40
Study 17311950 — intervention group
Group type: EXPERIMENTAL
Intervention: FeSO4
Number of subjects: 51
Study 17311950 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrolytic iron
Number of subjects: 51
Study 17311950 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced iron
Number of subjects: 51
Study 17311950 — intervention group
Group type: EXPERIMENTAL
Intervention: Heme iron
Number of subjects: 51
Study 17311950 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 15470872 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-modified glass ionomer (GI)
Number of subjects: 14
Study 15470872 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc phosphate (ZP)
Number of subjects: 14
Study 15470872 — intervention group
Group type: EXPERIMENTAL
Intervention: Resinous cement (RC)
Number of subjects: 14
Study 11468606 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical antibiotic ointment and occlusive patch over the affected eye (n=82)
Number of subjects: 163
Study 11468606 — intervention group
Group type: COMPARATOR
Intervention: Topical antibiotic ointment 4 times a day without an occlusive patch (n=81)
Number of subjects: 163
Study 9571349 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril (20 mg/day)
Number of subjects: 380
Study 9571349 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine (10 mg/day)
Number of subjects: 380
Study 8149360 — intervention group
Group type: EXPERIMENTAL
Intervention: L-tyrosine (10 g/day in four divided doses)
Number of subjects: 0
Study 8149360 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8149360 — intervention group
Group type: EXPERIMENTAL
Intervention: L-tyrosine
Number of subjects: 0
Study 2907520 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg)
Number of subjects: 12
Study 2907520 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg)
Number of subjects: 12
Study 2907520 — intervention group
Group type: EXPERIMENTAL
Intervention: L-bunolol (2 mg)
Number of subjects: 12
Study 2907520 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31084315 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional Cerebral Perfusion (RCP)
Number of subjects: 549
Study 31084315 — intervention group
Group type: COMPARATOR
Intervention: No Regional Cerebral Perfusion (No RCP)
Number of subjects: 549
Study 28415907 — intervention group
Group type: EXPERIMENTAL
Intervention: TPM/oxycodone patch
Number of subjects: 0
Study 28415907 — intervention group
Group type: COMPARATOR
Intervention: Vehicle patch
Number of subjects: 0
Study 26121805 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose amino acid administration (4 ml x kg(‐1) x hr(‐1))
Number of subjects: 30
Study 26121805 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose amino acid administration (2 ml x kg(‐1) x hr(‐1))
Number of subjects: 30
Study 26121805 — intervention group
Group type: COMPARATOR
Intervention: No amino acid administration
Number of subjects: 30
Study 23278295 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-use irradiation group using an LED device (420-nm blue light and 660-nm red light for 2.5 min twice daily for 4 weeks)
Number of subjects: 35
Study 23278295 — intervention group
Group type: COMPARATOR
Intervention: Control group using a sham device
Number of subjects: 35
Study 23278295 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-use irradiation group using an LED device
Number of subjects: 35
Study 21681157 — intervention group
Group type: EXPERIMENTAL
Intervention: High glycemic index (GI) recovery diet
Number of subjects: 10
Study 21681157 — intervention group
Group type: COMPARATOR
Intervention: Low glycemic index (GI) recovery diet
Number of subjects: 10
Study 19623014 — intervention group
Group type: EXPERIMENTAL
Intervention: siplizumab (0.012, 0.04, 0.12, or 0.4 mg/kg)
Number of subjects: 34
Study 19623014 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 34
Study 16686912 — intervention group
Group type: EXPERIMENTAL
Intervention: Migraine group (14 subjects)
Number of subjects: 33
Study 16686912 — intervention group
Group type: COMPARATOR
Intervention: Control group (19 subjects)
Number of subjects: 33
Study 15111632 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal splint (OS)
Number of subjects: 9
Study 15111632 — intervention group
Group type: COMPARATOR
Intervention: Palatal control device (PCD)
Number of subjects: 9
Study 11702968 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon laser photocoagulation
Number of subjects: 12
Study 9041974 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg salbutamol sulfate with 0.5 mg ipratropium bromide
Number of subjects: 342
Study 9041974 — intervention group
Group type: COMPARATOR
Intervention: 3 mg salbutamol sulfate alone
Number of subjects: 342
Study 7705095 — intervention group
Group type: EXPERIMENTAL
Intervention: CVR with 30 mcg EE
Number of subjects: 99
Study 7705095 — intervention group
Group type: EXPERIMENTAL
Intervention: CVR with 65 mcg EE
Number of subjects: 99
Study 7705095 — intervention group
Group type: EXPERIMENTAL
Intervention: CVR with 20 and 30 mcg EE
Number of subjects: 99
Study 7705095 — intervention group
Group type: COMPARATOR
Intervention: NA/EE oral contraceptives
Number of subjects: 99
Study 7705095 — intervention group
Group type: COMPARATOR
Intervention: EE/gestodene oral contraceptives
Number of subjects: 99
Study 3063728 — intervention group
Group type: EXPERIMENTAL
Intervention: Carteolol
Number of subjects: 63
Study 3063728 — intervention group
Group type: COMPARATOR
Intervention: Nadolol
Number of subjects: 63
Study 3063728 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 63
Study 31792304 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal therapy + anti-HER2
Number of subjects: 6234
Study 31792304 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy + anti-HER2
Number of subjects: 6234
Study 31792304 — intervention group
Group type: COMPARATOR
Intervention: Hormonal therapy
Number of subjects: 6234
Study 31792304 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 6234
Study 30217193 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention programme (walking group of 120 min/week, supervised, for 9 months)
Number of subjects: 207
Study 26912015 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal irrigation
Number of subjects: 81
Study 26912015 — intervention group
Group type: COMPARATOR
Intervention: Suction alone
Number of subjects: 81
Study 24641808 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized Cognitive Counseling (PCC) with rapid HIV testing
Number of subjects: 326
Study 24641808 — intervention group
Group type: COMPARATOR
Intervention: Rapid HIV testing only
Number of subjects: 326
Study 22610153 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC-D (3 cycles of FEC100 followed by 3 cycles of 100 mg/m(2) docetaxel)
Number of subjects: 1999
Study 22610153 — intervention group
Group type: COMPARATOR
Intervention: FEC (standard FEC100 for 6 cycles)
Number of subjects: 1999
Study 20543022 — intervention group
Group type: EXPERIMENTAL
Intervention: Online fatigue self-management programme
Number of subjects: 95
Study 20543022 — intervention group
Group type: EXPERIMENTAL
Intervention: Information-only fatigue self-management programme
Number of subjects: 95
Study 20543022 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 95
Study 20543022 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal Wellbeing Index
Number of subjects: 95
Study 20543022 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Subscale of the Fatigue Impact Scale
Number of subjects: 95
Study 17197223 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed of sound (SOS) measurement in osteoporosis group
Number of subjects: 117
Study 17197223 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed of sound (SOS) measurement
Number of subjects: 117
Study 17197223 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed of sound (SOS) measurement adjusted for age and BMI
Number of subjects: 117
Study 17197223 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed of sound (SOS) measurement adjusted for BMD
Number of subjects: 117
Study 17197223 — intervention group
Group type: EXPERIMENTAL
Intervention: Broadband ultrasound attenuation (BUA) measurement
Number of subjects: 117
Study 15572415 — intervention group
Group type: EXPERIMENTAL
Intervention: T enanthate, 200 mg im every 2 weeks, with placebo pills daily (T-only)
Number of subjects: 70
Study 15572415 — intervention group
Group type: EXPERIMENTAL
Intervention: T enanthate, 200 mg every 2 weeks, with 5 mg finasteride daily (T + F)
Number of subjects: 70
Study 15572415 — intervention group
Group type: COMPARATOR
Intervention: Placebo injections and pills
Number of subjects: 70
Study 12477979 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncontact normothermic wound therapy (NNWT)
Number of subjects: 40
Study 12477979 — intervention group
Group type: COMPARATOR
Intervention: Standard wound care (control)
Number of subjects: 40
Study 10401944 — intervention group
Group type: EXPERIMENTAL
Intervention: Q.E.D. Alcohol Test A350 (saliva)
Number of subjects: 100
Study 10401944 — intervention group
Group type: COMPARATOR
Intervention: Blood samples (alcohol dehydrogenase method)
Number of subjects: 100
Study 7781405 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest X-ray screening with sputum cytologic study (intensive and regular rescreening)
Number of subjects: 0
Study 7781405 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest X-ray screening (annual)
Number of subjects: 0
Study 7781405 — intervention group
Group type: COMPARATOR
Intervention: Chest X-ray screening (less frequent rescreening)
Number of subjects: 0
Study 2195517 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrashort-term prophylaxis for minor resections
Number of subjects: 200
Study 2195517 — intervention group
Group type: EXPERIMENTAL
Intervention: One-day antibiotic prophylaxis for major resections
Number of subjects: 200
Study 2195517 — intervention group
Group type: COMPARATOR
Intervention: Control group for minor resections (0 group)
Number of subjects: 200
Study 397017 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidoflazine
Number of subjects: 24
Study 397017 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 397017 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical training
Number of subjects: 24